ELI LILLY AND COMPANY Proceeds from (Repayments of) Short-term Debt
ELI LILLY AND COMPANY (LLY) reported Proceeds from (Repayments of) Short-term Debt of $5.28 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfShortTermDebt · last filed 2026-08-05
- ELI LILLY AND COMPANY proceeds from (repayments of) short-term debt for the quarter ending 2026-06-30 was $3.51B, a 118.90% increase year-over-year.
- ELI LILLY AND COMPANY proceeds from (repayments of) short-term debt for the quarter ending 2026-03-31 was $1.77B.
- ELI LILLY AND COMPANY proceeds from (repayments of) short-term debt for the quarter ending 2025-12-31 was -$400.00K, a 100.01% decline year-over-year.
- ELI LILLY AND COMPANY proceeds from (repayments of) short-term debt for the quarter ending 2025-09-30 was -$4.09B.
- ELI LILLY AND COMPANY proceeds from (repayments of) short-term debt for fiscal 2025 was -$4.34B.
- ELI LILLY AND COMPANY proceeds from (repayments of) short-term debt for fiscal 2024 was -$1.85B, a 139.48% decline from fiscal 2023.
- ELI LILLY AND COMPANY proceeds from (repayments of) short-term debt for fiscal 2023 was $4.69B, a 213.15% increase from fiscal 2022.
- ELI LILLY AND COMPANY proceeds from (repayments of) short-term debt for fiscal 2022 was $1.50B.
| Period end | Proceeds from (Repayments of) Short-term Debt 3 month | Proceeds from (Repayments of) Short-term Debt 3 month as first filed | Proceeds from (Repayments of) Short-term Debt 6 month | Proceeds from (Repayments of) Short-term Debt 6 month as first filed | Proceeds from (Repayments of) Short-term Debt 9 month | Proceeds from (Repayments of) Short-term Debt 9 month as first filed | Proceeds from (Repayments of) Short-term Debt 12 month | Proceeds from (Repayments of) Short-term Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.51B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $5.28B 10-Q · filed 2026-08-05 | $5.28B derived: sum of 3 quarters · filed 2026-08-05 | $1.19B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $1.77B 10-Q · filed 2026-04-30 | $1.77B derived: sum of 2 quarters · filed 2026-04-30 | -$2.32B derived: sum of 3 quarters · filed 2026-04-30 | -$714.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | -$400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$4.09B derived: sum of 2 quarters · filed 2026-02-12 | -$2.49B derived: sum of 3 quarters · filed 2026-08-05 | -$4.34B 10-K · filed 2026-02-12 | ||||
| 2025-09-30 | -$4.09B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$2.49B derived: sum of 2 quarters · filed 2026-08-05 | -$4.34B 10-Q · filed 2025-10-30 | -$1.30B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $1.60B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$246.00M 10-Q · filed 2026-08-05 | -$245.90M 10-Q · filed 2025-08-07 | $2.80B derived: sum of 3 quarters · filed 2026-08-05 | -$293.30M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | -$1.85B 10-Q · filed 2026-04-30 | -$1.85B 10-Q · filed 2025-05-01 | $1.19B derived: sum of 2 quarters · filed 2026-04-30 | -$1.90B derived: sum of 3 quarters · filed 2026-04-30 | $1.50B derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2024-12-31 | $3.04B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$47.30M derived: sum of 2 quarters · filed 2026-02-12 | $3.35B derived: sum of 3 quarters · filed 2026-02-12 | -$1.85B 10-K · filed 2026-02-12 | -$1.85B 10-K · filed 2025-02-19 | |||
| 2024-09-30 | -$3.09B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $310.70M derived: sum of 2 quarters · filed 2025-10-30 | -$4.89B 10-Q · filed 2025-10-30 | -$300.10M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-06-30 | $3.40B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.80B 10-Q · filed 2025-08-07 | $2.79B derived: sum of 3 quarters · filed 2026-02-12 | $4.38B derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-03-31 | -$5.20B 10-Q · filed 2025-05-01 | -$610.80M derived: sum of 2 quarters · filed 2026-02-12 | $984.20M derived: sum of 3 quarters · filed 2026-02-12 | $984.20M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2023-12-31 | $4.59B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $6.19B derived: sum of 2 quarters · filed 2026-02-12 | $6.19B derived: sum of 3 quarters · filed 2026-02-12 | $4.69B 10-K · filed 2026-02-12 | $4.69B 10-K · filed 2024-02-21 | |||
| 2023-09-30 | $1.59B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $1.59B derived: sum of 2 quarters · filed 2024-10-30 | $97.00M 10-Q · filed 2024-10-30 | -$146.30M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$1.50B 10-Q · filed 2024-08-08 | -$1.74B derived: sum of 3 quarters · filed 2025-02-19 | -$2.12B derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-03-31 | -$1.50B 10-Q · filed 2024-04-30 | -$1.74B derived: sum of 2 quarters · filed 2025-02-19 | -$2.12B derived: sum of 3 quarters · filed 2025-02-19 | -$499.70M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2022-12-31 | -$243.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | -$619.20M derived: sum of 2 quarters · filed 2025-02-19 | $998.30M derived: sum of 3 quarters · filed 2025-02-19 | $1.50B 10-K · filed 2025-02-19 | ||||
| 2022-09-30 | -$375.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.24B derived: sum of 2 quarters · filed 2023-11-02 | $1.74B 10-Q · filed 2023-11-02 | |||||
| 2022-06-30 | $1.62B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $2.12B 10-Q · filed 2023-08-08 | ||||||
| 2022-03-31 | $499.70M 10-Q · filed 2023-04-27 | |||||||
| 2021-12-31 | -$4.00M 10-K · filed 2024-02-21 | |||||||
| 2020-12-31 | -$1.49B 10-K · filed 2023-02-22 | |||||||
| 2019-12-31 | $995.40M 10-K · filed 2022-02-23 | |||||||
| 2019-06-30 | -$286.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $1.56B 10-Q · filed 2019-08-02 | $1.66B derived: sum of 3 quarters · filed 2021-02-17 | -$384.90M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-03-31 | $1.85B 10-Q · filed 2019-05-02 | $1.95B derived: sum of 2 quarters · filed 2021-02-17 | -$98.80M derived: sum of 3 quarters · filed 2021-02-17 | $855.00M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2018-12-31 | $99.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | -$1.95B derived: sum of 2 quarters · filed 2021-02-17 | -$995.40M derived: sum of 3 quarters · filed 2021-02-17 | -$2.20B 10-K · filed 2021-02-17 | ||||
| 2018-09-30 | -$2.05B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$1.09B derived: sum of 2 quarters · filed 2019-08-02 | -$2.30B 10-Q · filed 2018-11-06 | -$2.13B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | $953.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | -$248.70M 10-Q · filed 2019-08-02 | -$78.00M derived: sum of 3 quarters · filed 2020-02-19 | $1.02B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | -$1.20B 10-Q · filed 2019-05-02 | -$1.03B derived: sum of 2 quarters · filed 2020-02-19 | $69.30M derived: sum of 3 quarters · filed 2020-02-19 | -$302.50M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | $170.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $1.27B derived: sum of 2 quarters · filed 2020-02-19 | $900.00M derived: sum of 3 quarters · filed 2020-02-19 | $1.40B 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | $1.10B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $729.30M derived: sum of 2 quarters · filed 2018-11-06 | $1.23B 10-Q · filed 2018-11-06 | $2.52B derived: sum of 4 quarters · filed 2019-10-24 | ||||
| 2017-06-30 | -$371.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-25 | $125.70M 10-Q · filed 2018-07-25 | $1.42B derived: sum of 3 quarters · filed 2019-10-24 | $1.42B derived: sum of 4 quarters · filed 2019-10-24 | ||||
| 2017-03-31 | $497.50M 10-Q · filed 2018-04-27 | $1.79B derived: sum of 2 quarters · filed 2019-10-24 | $1.79B derived: sum of 3 quarters · filed 2019-10-24 | $1.79B derived: sum of 4 quarters · filed 2019-10-24 | ||||
| 2016-12-31 | $1.29B derived: 8-K 12 month − 10-Q 9 month · filed 2019-10-24 | $1.29B derived: sum of 2 quarters · filed 2019-10-24 | $1.29B derived: sum of 3 quarters · filed 2019-10-24 | $1.29B 8-K · filed 2019-10-24 | ||||
| 2016-09-30 | -$300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | -$600.00K derived: sum of 2 quarters · filed 2017-10-27 | -$1.70M 10-Q · filed 2017-10-27 | -$1.60M derived: sum of 4 quarters · filed 2018-02-20 | ||||
| 2016-06-30 | -$300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | -$1.40M 10-Q · filed 2017-07-28 | -$1.30M derived: sum of 3 quarters · filed 2018-02-20 | -$2.70M derived: sum of 4 quarters · filed 2018-02-20 | ||||
| 2016-03-31 | -$1.10M 10-Q · filed 2017-05-01 | -$1.00M derived: sum of 2 quarters · filed 2018-02-20 | -$2.40M derived: sum of 3 quarters · filed 2018-02-20 | -$593.10M derived: sum of 4 quarters · filed 2018-02-20 | ||||
| 2015-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | -$1.30M derived: sum of 2 quarters · filed 2018-02-20 | -$592.00M derived: sum of 3 quarters · filed 2018-02-20 | -$2.68B 10-K · filed 2018-02-20 | ||||
| 2015-09-30 | -$1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | -$592.10M derived: sum of 2 quarters · filed 2016-10-28 | -$2.68B 10-Q · filed 2016-10-28 | -$305.00M derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2015-06-30 | -$590.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | -$2.68B 10-Q · filed 2016-07-28 | -$303.60M derived: sum of 3 quarters · filed 2017-02-21 | -$1.00M derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2015-03-31 | -$2.09B 10-Q · filed 2016-04-29 | $287.10M derived: sum of 2 quarters · filed 2017-02-21 | $589.70M derived: sum of 3 quarters · filed 2017-02-21 | $592.00M derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2014-12-31 | $2.38B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $2.68B derived: sum of 2 quarters · filed 2017-02-21 | $2.68B derived: sum of 3 quarters · filed 2017-02-21 | $2.68B 10-K · filed 2017-02-21 | ||||
| 2014-09-30 | $302.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $304.90M derived: sum of 2 quarters · filed 2015-10-30 | $304.90M 10-Q · filed 2015-10-30 | $304.90M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | $2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $2.30M 10-Q · filed 2015-07-30 | $2.30M derived: sum of 3 quarters · filed 2016-02-19 | $2.30M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | $0.00 10-Q · filed 2015-04-30 | $0.00 derived: sum of 2 quarters · filed 2016-02-19 | $0.00 derived: sum of 3 quarters · filed 2016-02-19 | $0.00 derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $0.00 derived: sum of 2 quarters · filed 2016-02-19 | $0.00 derived: sum of 3 quarters · filed 2016-02-19 | $0.00 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $0.00 derived: sum of 2 quarters · filed 2014-10-29 | $0.00 10-Q · filed 2014-10-29 | $6.70M derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-28 | $0.00 10-Q · filed 2014-07-28 | $6.70M derived: sum of 3 quarters · filed 2015-02-19 | $6.70M derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2013-03-31 | $0.00 10-Q · filed 2013-04-26 | $6.70M derived: sum of 2 quarters · filed 2015-02-19 | $6.70M derived: sum of 3 quarters · filed 2015-02-19 | $5.30M derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2012-12-31 | $6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $6.70M derived: sum of 2 quarters · filed 2015-02-19 | $5.30M derived: sum of 3 quarters · filed 2015-02-19 | $0.00 10-K · filed 2015-02-19 | -$10.50M 10-K · filed 2013-02-21 | |||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | -$1.40M derived: sum of 2 quarters · filed 2013-10-30 | -$6.70M 10-Q · filed 2013-10-30 | -$15.20M 10-Q · filed 2012-10-26 | -$112.20M derived: sum of 4 quarters · filed 2014-02-19 | |||
| 2012-06-30 | -$1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-26 | -$6.70M 10-Q · filed 2013-07-26 | -$14.70M 10-Q · filed 2012-07-27 | -$112.20M derived: sum of 3 quarters · filed 2014-02-19 | -$12.30M derived: sum of 4 quarters · filed 2014-02-19 | |||
| 2012-03-31 | -$5.30M 10-Q · filed 2013-04-26 | -$12.40M 10-Q · filed 2012-04-30 | -$110.80M derived: sum of 2 quarters · filed 2014-02-19 | -$10.90M derived: sum of 3 quarters · filed 2014-02-19 | -$23.20M derived: sum of 4 quarters · filed 2014-02-19 | |||
| 2011-12-31 | -$105.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-19 | -$5.60M derived: sum of 2 quarters · filed 2014-02-19 | -$17.90M derived: sum of 3 quarters · filed 2014-02-19 | -$134.10M 10-K · filed 2014-02-19 | -$141.20M 10-K · filed 2012-02-24 | |||
| 2011-09-30 | $99.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-26 | $87.60M derived: sum of 2 quarters · filed 2012-10-26 | -$28.60M 10-Q · filed 2012-10-26 | -$28.60M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-06-30 | -$12.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27 | -$128.50M 10-Q · filed 2012-07-27 | -$128.50M derived: sum of 3 quarters · filed 2013-02-21 | -$2.10M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-03-31 | -$116.20M 10-Q · filed 2012-04-30 | -$116.20M derived: sum of 2 quarters · filed 2013-02-21 | $10.20M derived: sum of 3 quarters · filed 2013-02-21 | $16.80M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $126.40M derived: sum of 2 quarters · filed 2013-02-21 | $133.00M derived: sum of 3 quarters · filed 2013-02-21 | $125.10M 10-K · filed 2013-02-21 | $123.90M 10-K · filed 2011-02-22 | |||
| 2010-09-30 | $126.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $133.00M derived: sum of 2 quarters · filed 2011-10-28 | $125.10M 10-Q · filed 2011-10-28 | -$869.70M derived: sum of 4 quarters · filed 2012-02-24 | ||||
| 2010-06-30 | $6.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-29 | -$1.30M 10-Q · filed 2011-07-29 | -$996.10M derived: sum of 3 quarters · filed 2012-02-24 | -$1.01B derived: sum of 4 quarters · filed 2012-02-24 | ||||
| 2010-03-31 | -$7.90M 10-Q · filed 2011-04-29 | -$1.00B derived: sum of 2 quarters · filed 2012-02-24 | -$1.02B derived: sum of 3 quarters · filed 2012-02-24 | -$1.59B derived: sum of 4 quarters · filed 2012-02-24 | ||||
| 2009-12-31 | -$994.80M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24 | -$1.01B derived: sum of 2 quarters · filed 2012-02-24 | -$1.58B derived: sum of 3 quarters · filed 2012-02-24 | -$5.82B 10-K · filed 2012-02-24 | ||||
| 2009-09-30 | -$16.60M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-10-29 | -$585.80M derived: sum of 2 quarters · filed 2010-10-29 | -$4.83B 10-Q · filed 2010-10-29 | $623.30M derived: sum of 4 quarters · filed 2011-02-22 | ||||
| 2009-06-30 | -$569.20M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2010-08-02 | -$4.81B 10-Q/A · filed 2010-08-02 | $639.90M derived: sum of 3 quarters · filed 2011-02-22 | $597.00M derived: sum of 4 quarters · filed 2011-02-22 | ||||
| 2009-03-31 | -$4.24B 10-Q · filed 2010-07-30 | $1.21B derived: sum of 2 quarters · filed 2011-02-22 | $1.17B derived: sum of 3 quarters · filed 2011-02-22 | |||||
| 2008-12-31 | $5.45B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-22 | $5.41B derived: sum of 2 quarters · filed 2011-02-22 | $5.06B 10-K · filed 2011-02-22 | |||||
| 2008-09-30 | -$42.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-30 | -$392.20M 10-Q · filed 2009-10-30 | ||||||
| 2008-06-30 | -$349.30M 10-Q · filed 2009-07-31 | |||||||
| 2007-12-31 | -$468.50M 10-K · filed 2010-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |